Oasis Diagnostics® Corporation was found in 2002 to address a growing need for non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics (DNA, RNA and proteins) in the Life Sciences area. The Company is dedicated to meeting the need for more effective screening tools, which may be applied to the early detection of diseases and medical disorders, utilizing non-invasive test specimens and particularly oral fluids (saliva).The Company’s range of collection and (future) diagnostic tools are covered by a portfolio of issued US, EU and International patents.

Recognizing that early diagnosis is the key to disease prevention on a global basis, the Company directs its research efforts towards the development of oral based rapid, point-of-care, laboratory-based and molecular products, which fit into a Corporate objective of improving the quality of healthcare for our global customers.

PureSAL ™ - Collection cell-free RNA, DNA and proteins from saliva
SimplOFy™ - Collection and stabilization of salivary DNA
Super•SAL™ - Universal collection tool for saliva samples
PediaSAL - Collection from Neonates and Infants
DNA-SAL - Collection of DNA from the oral cavity
RNAPro•SAL™ - Split sample collection of cell free RNA/DNA
Accu•SAL™ - Universal saliva collection for drugs
Micro•SAL™ - Universal small volume collection
Versi•SAL™ and travel
Versi•SAL™/(Travel) - General versatile saliva collector or Travel Cover
MiniSAL / MidiSAL - Isolation of DNA from 0.1ml – 1.0/3.0ml of oral specimin
UltraSal-2™ - Large volume split sample collector
FemCollect - Collection of cells/DNA from the vaginal canal
Share on facebook
Share on email
Share on linkedin

Copyright © 2020 Goffin Molecular Technologies